Mahana Therapeutics, a leading provider of digital chronic condition management programs, announces that it has acquired Berlin-based HiDoc Technologies GmbH, operating as Cara Care, a leader in digital digestive healthcare. This combination creates a global company offering the most comprehensive digestive health portfolio currently addressing Irritable Bowel Syndrome (IBS), Irritable Bowel Disorder (IBD), Celiac Disease and Heartburn, with an exciting pipeline focused on Tinnitus, Pruritus, and Vulvodynia. The acquisition of Cara Care is expected to accelerate Mahana’s market entry in Europe where the reimbursement of digital programs is outpacing the United States.
Read the full article: Mahana Therapeutics Acquires Cara Care to Become a Global Leader in the Digital Treatment of Chronic Conditions //
Source: https://www.businesswire.com/news/home/20240312168462/en/Mahana-Therapeutics-Acquires-Cara-Care-to-Become-a-Global-Leader-in-the-Digital-Treatment-of-Chronic-Conditions